Skip to content

AOCI at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$24.8M-63.6%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$1.06M-26.0%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
-$880K-6.7%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$1.03M-2,751%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$558K-328%
Immunome logo
ImmunomeIMNM
$0-100%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's AOCI?
Vera Therapeutics (VERA) reported AOCI of -$156K in Q1 2026.
How has Vera Therapeutics's AOCI changed year-over-year?
Vera Therapeutics's AOCI decreased by 123.9% year-over-year, from $654K to -$156K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.